Medical/Pharmaceuticals
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
* Xpert® MTB/XDR cartridge enables expanded drug-resistance profiling in less than 90 minutes * Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), the test could help fill a critical gap that is cu...
2020-07-16 19:00
12913
Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, July 16, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company, today announced that the Company presented preclinical data from a fully human CD73 antibody (HBM1007) in an e-poster at the American...
2020-07-16 18:00
4212
PerfectPrime Unleashes World's First Handheld Thermal Camera For Fever Detection with Top Accuracy
HONG KONG, July 16, 2020 /PRNewswire/ -- The world is facing a never before seen crisis which has cost economies billions of dollars and affected an unprecedented number of lives. The coronavirus has forced people to stay home and out of work at its peak but businesses are now slowly opening up a...
2020-07-16 17:00
1426
Getinge Interim Report January-June 2020: Making a Real Difference Together With our Customers
GOTHENBURG, Sweden, July 16, 2020 /PRNewswire/ -- "During this year's second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry," says Mattias Perjos, Pr...
2020-07-16 14:19
9740
I-Mab Announces Authorization of Stock Repurchase Program up to $20 Million
SHANGHAI and GAITHERSBURG, Md., July 15, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that its Board of Directors has authorized a stock repur...
2020-07-16 04:15
22177
Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs)
PALO ALTO, Calif., July 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe
, https://ipeace.com/
2020-07-16 00:00
1529
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Waldenström Macroglobulinemia
SUZHOU, China and ROCKVILLE, Md., July 15, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...
2020-07-15 21:07
2222
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
TOKYO and DEVENTER, Netherlands, July 15, 2020 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., aNetherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radia...
2020-07-15 14:05
18438
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics held a signing ceremony today for a contract to develop and manufacture five candidate molecules, expanding upon the two companies' existing CDO partnership first established in 2018. ...
2020-07-15 13:46
1838
Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner
SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...
2020-07-15 07:00
14439
Mexico Telecommunication Giant, Alestra, Deploys Bright Pattern Contact Center Software for CENACED's Telehealth Services During COVID-19
Alestra, deploys Bright Pattern Contact Center for nonprofit, CENACED, to offer remote psychological teleassistance services during the pandemic SOUTH SAN FRANCISCO, California, July 15, 2020 /PRNewswire/ -- CENACED, a non-profit healthcare organization, has deployed Bright Pattern as their clou...
2020-07-15 02:30
2135
Discover the Power of VUNO's AI Solutions at ECR 2020
SEOUL, South Korea, July 14, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions t...
2020-07-14 22:20
2020
University of Toronto Tests Confirm First Mask That Deactivates Coronavirus
MIRABEL, Quebec, July 14, 2020 /PRNewswire/ -- i3 BioMedical Inc. today announced that a team of scientists at theUniversity of Toronto tested and established that the virus SARS-CoV-2, which causes Covid-19, cannot be recovered after being applied to the TrioMed Active mask. The mask's external ...
2020-07-14 20:25
5157
UL Helps Advance Vaccination Storage Technologies with New World Health Organization Accreditation
With an anticipated surge in the need for vaccine storage in preparation for COVID-19 vaccination release, World Health Organization accredited testing will help refrigeration OEMs ensure refrigeration reliability and temperature consistency impacting overall vaccine efficacy. BENGALURU, India, ...
2020-07-14 20:00
3075
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
SHANGHAI, July 14, 2020 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) announces that its subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. ("Fosun Pharmaceutical Industrial") has received the acceptance no...
2020-07-14 20:00
9914
Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China
HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (stock code: 2500.HK), the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating...
2020-07-14 18:19
19051
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia
SAN DIEGO and SAFFRON WALDEN, United Kingdom, July 14, 2020 /PRNewswire/ -- Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise ...
2020-07-14 18:00
2802
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology
Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...
2020-07-14 09:30
3052
Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies With Precision-Targeted T-Cell Engaging Antibodies
- Novel antibody-based cancer immunotherapies to be developed through combining Revitope's dual-antigen precision T-cell engager platform (TEAC) and Junshi Biosciences' antibodies - Revitope to design up to 5 TEAC molecules against tumor targets selected by Junshi Biosciences - For each TEAC mo...
2020-07-14 09:01
6503
Zuellig Pharma appoints John Graham as new CEO
SINGAPORE, July 14, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare
services provider inAsia, announces the appointment of John Graham as its new
CEO. John will run theUS$13 billion business and lead the team across 13
markets inAsia.
2020-07-14 09:00
9408
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685